Article
SLC6A1 variants identified in epilepsy patients reduce γ-aminobutyric acid transport.
Epilepsia - 1 Sept 2018
Mattison Kari A, Butler Kameryn M, Inglis George Andrew S, Dayan Oshrat, Boussidan Hanna, Bhambhani Vikas, Philbrook Bryan, da Silva Cristina, Alexander John J, Kanner Baruch I, Escayg Andrew
Abstract excerpt
Previous reports have identified SLC6A1 variants in patients with generalized epilepsies, such as myoclonic-atonic epilepsy and childhood absence epilepsy. However, to date, none of the identified SLC6A1 variants has been functionally tested for an effect on GAT-1 transporter activity. The purpose of this study was to determine the incidence of SLC6A1 variants in 460 unselected epilepsy patients and to evaluate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
